FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4384078777> ?p ?o ?g. }

• W4384078777 endingPage "21162" @default.
• W4384078777 startingPage "21153" @default.
• W4384078777 abstract "Benzimidazolones have shown biological activities, including antihyperglycemic and hypoglycemic, by inhibiting or activating of α-glu and GK. The aim of this study is the rational design of compounds using in silico assays to delimitate the selection of structures to synthesize and the in vitro evaluation of benzimidazolone derivatives in blood glucose control. A docking of 23 benzimidazolone derivatives was performed; selecting the compounds with better in silico profiles to synthesize by microwave-irradiation/conventional heat and evaluate in enzymatic in vitro evaluation. Compounds 2k, 2m, 2r, and 2s presented the best in silico profiles, showing good affinity energy (-10.9 to -8.6 kcal mol-1) and binding with catalytic-amino acids. They were synthesized at 70 °C and 24 h using DMF as the solvent and potassium carbonate (yield: 22-38%). The results with α-glu showed moderate inhibition of 2k (14 ± 1.23-29 ± 0.45), 2m (12 ± 2.21-36 ± 0.30), 2r (7 ± 2.21-13 ± 1.34), and 2s (11 ± 0.74-35 ± 2.95) at evaluated concentrations (0.1 to 100 μg mL-1). The GK activation assay showed an enzymatic activity increase; compound 2k increased 1.31 and 2.83 more than normal activity, 2m (2.13-fold), 2s (2.86 and 3.74-fold) at 100 and 200 μg mL-1 respectively. The present study showed that the 2s derivative presents moderate potential as an α-glu inhibitor and a good activator potential of GK, suggesting that this compound is a good candidate for blood glucose control through antihyperglycemic and hypoglycemic mechanisms." @default.
• W4384078777 created "2023-07-13" @default.
• W4384078777 creator A5008364779 @default.
• W4384078777 creator A5010805609 @default.
• W4384078777 creator A5017270592 @default.
• W4384078777 creator A5022131324 @default.
• W4384078777 creator A5026783461 @default.
• W4384078777 creator A5028020419 @default.
• W4384078777 creator A5037376834 @default.
• W4384078777 creator A5043064447 @default.
• W4384078777 creator A5045763993 @default.
• W4384078777 creator A5071586196 @default.
• W4384078777 date "2023-01-01" @default.
• W4384078777 modified "2023-10-18" @default.
• W4384078777 title "Design, synthesis, <i>in silico</i>, and <i>in vitro</i> evaluation of benzylbenzimidazolone derivatives as potential drugs on α-glucosidase and glucokinase as pharmacological targets" @default.
• W4384078777 cites W1575122226 @default.
• W4384078777 cites W1972490015 @default.
• W4384078777 cites W1977495823 @default.
• W4384078777 cites W2005561360 @default.
• W4384078777 cites W2014190569 @default.
• W4384078777 cites W2053117958 @default.
• W4384078777 cites W2059067578 @default.
• W4384078777 cites W2059116779 @default.
• W4384078777 cites W2059778013 @default.
• W4384078777 cites W2319152349 @default.
• W4384078777 cites W2613977845 @default.
• W4384078777 cites W2729116304 @default.
• W4384078777 cites W2782233870 @default.
• W4384078777 cites W2783002859 @default.
• W4384078777 cites W2790071180 @default.
• W4384078777 cites W2805128692 @default.
• W4384078777 cites W2898184057 @default.
• W4384078777 cites W2912232304 @default.
• W4384078777 cites W2943804196 @default.
• W4384078777 cites W2972150577 @default.
• W4384078777 cites W2990231378 @default.
• W4384078777 cites W2996738965 @default.
• W4384078777 cites W3010980339 @default.
• W4384078777 cites W3034267231 @default.
• W4384078777 cites W3043541128 @default.
• W4384078777 cites W3135870430 @default.
• W4384078777 cites W3158716590 @default.
• W4384078777 cites W3193144198 @default.
• W4384078777 cites W4206940146 @default.
• W4384078777 doi "https://doi.org/10.1039/d3ra02916f" @default.
• W4384078777 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37449031" @default.
• W4384078777 hasPublicationYear "2023" @default.
• W4384078777 type Work @default.
• W4384078777 citedByCount "0" @default.
• W4384078777 crossrefType "journal-article" @default.
• W4384078777 hasAuthorship W4384078777A5008364779 @default.
• W4384078777 hasAuthorship W4384078777A5010805609 @default.
• W4384078777 hasAuthorship W4384078777A5017270592 @default.
• W4384078777 hasAuthorship W4384078777A5022131324 @default.
• W4384078777 hasAuthorship W4384078777A5026783461 @default.
• W4384078777 hasAuthorship W4384078777A5028020419 @default.
• W4384078777 hasAuthorship W4384078777A5037376834 @default.
• W4384078777 hasAuthorship W4384078777A5043064447 @default.
• W4384078777 hasAuthorship W4384078777A5045763993 @default.
• W4384078777 hasAuthorship W4384078777A5071586196 @default.
• W4384078777 hasBestOaLocation W43840787771 @default.
• W4384078777 hasConcept C104317684 @default.
• W4384078777 hasConcept C134121241 @default.
• W4384078777 hasConcept C181199279 @default.
• W4384078777 hasConcept C185592680 @default.
• W4384078777 hasConcept C191897082 @default.
• W4384078777 hasConcept C192562407 @default.
• W4384078777 hasConcept C202751555 @default.
• W4384078777 hasConcept C2775905019 @default.
• W4384078777 hasConcept C55493867 @default.
• W4384078777 hasConcept C71240020 @default.
• W4384078777 hasConcept C98335778 @default.
• W4384078777 hasConceptScore W4384078777C104317684 @default.
• W4384078777 hasConceptScore W4384078777C134121241 @default.
• W4384078777 hasConceptScore W4384078777C181199279 @default.
• W4384078777 hasConceptScore W4384078777C185592680 @default.
• W4384078777 hasConceptScore W4384078777C191897082 @default.
• W4384078777 hasConceptScore W4384078777C192562407 @default.
• W4384078777 hasConceptScore W4384078777C202751555 @default.
• W4384078777 hasConceptScore W4384078777C2775905019 @default.
• W4384078777 hasConceptScore W4384078777C55493867 @default.
• W4384078777 hasConceptScore W4384078777C71240020 @default.
• W4384078777 hasConceptScore W4384078777C98335778 @default.
• W4384078777 hasFunder F4320329453 @default.
• W4384078777 hasIssue "31" @default.
• W4384078777 hasLocation W43840787771 @default.
• W4384078777 hasLocation W43840787772 @default.
• W4384078777 hasOpenAccess W4384078777 @default.
• W4384078777 hasPrimaryLocation W43840787771 @default.
• W4384078777 hasRelatedWork W1997835187 @default.
• W4384078777 hasRelatedWork W2015242672 @default.
• W4384078777 hasRelatedWork W2016627433 @default.
• W4384078777 hasRelatedWork W2051491674 @default.
• W4384078777 hasRelatedWork W2171525001 @default.
• W4384078777 hasRelatedWork W21734586 @default.
• W4384078777 hasRelatedWork W2743565641 @default.
• W4384078777 hasRelatedWork W2784885010 @default.
• W4384078777 hasRelatedWork W2949184651 @default.

• next